
Deep Dive: How Eli Lilly Became the First $1 Trillion Healthcare Company
The Rundown
00:00
Valuation and investment takeaway
Zaid weighs bullish prospects against a high forward P/E and the risk of a small earnings miss triggering a correction.
Play episode from 11:02
Transcript


